Biotechnology News

September 5, 2014

SAN ANTONIO--(BUSINESS WIRE)--KCI Partners with B. Braun Medical to sell Prontosan® Wound Irrigation Solution for use with V.A.C. VeraFlo™ Negative Pressure Wound Therapy

September 5, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Highlights Study Involving ARROW PICC with Chlorag+ard Technology, Showing Significant Reduction in PICC-Related Bloodstream Infections

September 5, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS’ FOUNDER LEADS STUDY IDENTIFYING A NOVEL MECHANISM FOR TREATING INFLAMMATORY BOWEL DISEASE

September 5, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare &...

September 5, 2014

MUNICH & RIGA, Latvia--(BUSINESS WIRE)--Corporate Education Session to stress the importance of water   Diaverum, one of the world’s leading integrated renal care providers, is hosting a Corporate Education Session at the 43nd EDTNA/ERCA...

September 4, 2014

BEND, Ore.--(BUSINESS WIRE)--Agere to Present Innovations in Oral Bioavailability Formulations Using Quadrant 2™ Platform

September 4, 2014

ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix, Inc., a developer of fully automated molecular testing solutions, recently lectured in China on its breakthrough in vitro diagnostics platform, the EncompassMDx.

September 4, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Reports Inducement Grants to New Chief Executive Officer

September 4, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the...

September 4, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCBB:PRTX), a clinical-stage biopharmaceutical company, today announces its participation in the Rodman & Renshaw Annual Global Investment Conference to be held September 8-10, 2014 at the...

September 4, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy

September 4, 2014

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Ascendia advances nano-emulsion platform technology with parenteral clopidogrel program.

September 4, 2014

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac’s best-in-class clinical Supply Chain Management (SCM) service combines consultancy and supportive technology that helps sponsor companies overcome technological, logistical and planning...

September 4, 2014

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, Inc., announced today that MedStar Georgetown University Hospital has received final approval to begin construction of the first proton therapy center in Washington, D.C. at its Lombardi...

September 4, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) invites biotechnology experts to submit novel and cutting-edge topic proposals for sessions at the 2015 BIO International Convention.

September 4, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector.

September 4, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced SureGuide, the first in a new series of kits to advance genome editing and synthetic biology. The complete SureGuide workflow includes a SureGuide Cas9...

September 4, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a global full-service contract research organization, are further strengthening their clinical trial management approaches in the area of Infectious Diseases.

September 4, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--Dr. Susan Dallabrida, VP at patient-driven eData innovator PHT Corp., will present a poster, Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma at the ESMO 2014 Congress.

September 4, 2014

SAN ANTONIO--(BUSINESS WIRE)--DPT Laboratories, a contract development and manufacturing organization (CDMO), announces the acquisition of Meda Pharmaceuticals' Lakewood, New Jersey, facilities.

September 4, 2014

MADISON, Wis.--(BUSINESS WIRE)--The 25th International Symposium on Human Identification (ISHI) 2014 will be held September 29–October 2 at the Arizona Biltmore, 2400 East Missouri Avenue, Phoenix, Arizona.

September 4, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter D. Suzdak, PhD, the Company’s...

September 4, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck’s Investigational Beta-lactamase Inhibitor Relebactam (MK-7655) Granted Qualified Infectious Disease Product (QIDP) and Fast Track Designations by FDA

September 4, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®; NYSE: LH) announced today the launch of Enlighten Health Genomics, a new business that builds on the diagnostic potential of Next-Generation Sequencing (NGS...

September 4, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Morgan Stanley 2014 Global Health Care...

September 4, 2014

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says data in the New England Journal of Medicine confirm REVLIMID plus low-dose dexamethasone improves survival in newly diagnosed myeloma patients not eligible for a stem cell transplant.

September 4, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida announces discovery of a clinical candidate for treatment of complications of cardiorenal disease; $10 million Series A financing by OrbiMed, Sibling Capital and Limulus Venture Partners.

September 4, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. has received a U.S. patent allowance for noscapine, which covers the treatment of ALS, Parkinson's disease, and diabetic neuropathy.

September 4, 2014

AUSTIN, Texas & BELFAST, United Kingdom--(BUSINESS WIRE)--Asuragen, a molecular diagnostics company using genomics to drive better patient management, and Labceutics, the leading global personalized medicine laboratory network, announced...

September 4, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus released preliminary revenues for its 4th fiscal quarter of FY2014. Revenues increased 15.1%, to $1.805 million, over 4QFY13. For FY2014, preliminary revenues were up 11.9% over FY13.

September 4, 2014

VICTORIA, British Columbia--(BUSINESS WIRE)--GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers.

September 4, 2014

YOKNEAM, Israel--(BUSINESS WIRE)--EndoCross receives CE Mark on the ENABLER-C Coronary Catheter System for the treatment of Coronary Chronic Total Occlusions (CTO).

September 4, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announces the launch of the generic equivalent to Baraclude® (Entecavir) Tablets, 0.5mg and 1mg, in the United States. Teva was first to file, making the product...

September 4, 2014

TOULOUSE, France--(BUSINESS WIRE)--GamaMabs Pharma announces two scientific communications on its AMHR2 project.

September 4, 2014

MONTCLAIR, N.J.--(BUSINESS WIRE)--MetaStat's CEO, Dr. Oscar Bronsther, M.D., will be speaking at the Aegis Capital Conference on September 11 at 3:30 PM Pacific Time. He will provide an overview of the company.

September 4, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the U.S. Patent and Trademark Office granted the company its fourth patent allowance related to its proprietary microneedle drug delivery methods and devices.

September 4, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea signs a development and commercialization agreement for Lymphoseek with Hainan Sinotau Pharmaceutical aimed at gaining regulatory approval with China FDA and sales in China.

September 4, 2014

BASEL, Switzerland--(BUSINESS WIRE)--"In my 30 years of business I have not experienced such enthusiasm and commitment from a prospective partner to support and drive a process - not with aggression but with patience and competence."

September 4, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Phase III study of continuous REVLIMID and dexamethasone published in New England Journal of Medicine.

September 4, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Michael Rogers, Acorda’s Chief Financial Officer, will present at the Aegis Capital 2014 Healthcare and Technology Conference. The conference will take...

September 4, 2014

HAYWARD, Calif.--(BUSINESS WIRE)--FDA has granted Fast Track designation to Aradigm's lead product candidate, Pulmaquin, for non-cystic fibrosis bronchiectasis.

September 4, 2014

CHICAGO--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, today announced that Stephen M. Simes, RestorGenex’...

September 4, 2014

RICHMOND, Va.--(BUSINESS WIRE)--AmpliPhi to present Next Generation Antibacterial Agents with in vitro efficacy to kill multi drug resistant bacteria; MRSA, VRSA

September 4, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes™ announced today platinum recording artist Kris Allen, best known for winning season eight of ‘American Idol’; singer/songwriter Jessi Malay; and dance team Culture Shock LA will perform.

September 4, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces results from the complete analysis of the European Phase 2/3 clinical study of its...

September 4, 2014

PARIS--(BUSINESS WIRE)--Cellectis announces the closing of the sale of its Swedish subsidiary Cellectis AB to Takara Bio Inc.

September 4, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today the pricing of $250 million aggregate principal amount of its 2.50% convertible senior notes due 2021 in a private placement to qualified institutional buyers...